Article

Incidence and management of the main adverse effects reported after COVID-19 vaccination

2023-09-05

Abstract excerpt

Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first appeared in Wuhan, China in 2019. Soon after, it was declared a pandemic by the World Health Organization (WHO). The health crisis imposed by a new virus and its rapid spread worldwide prompted the fast development of vaccines. For the first time in human history, two vaccines based on recombinant g...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e790f726-cda9-5fa9-8fce-0ad9a7f0a1e1
DOI: 10.22541/au.169391537.70939672/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Incidence and management of the main adverse effects reported after COVID-19 vaccinationDOI 10.22541/au.169391537.70939672/v1Read

Serious adverse events reported from the COVID-19 vaccines: A descriptive study based on WHO databaseSemantic proximity Read

Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillanceSemantic proximity Read

Adverse events of special interest for COVID-19 vaccines - background incidences vary by sex, age and time period and are affected by the pandemicSemantic proximity Read

Review on different COVID-19 vaccines approved for Emergency Use Listing by WHO until 11 July 2022: characterization, pharmacological properties, mechanism of action and adverse events.Semantic proximity Read

A 6-week time period may not be sufficient to identify potential adverse events following COVID-19 vaccinationSemantic proximity Read

Cohort monitoring of 29 Adverse Events of Special Interest prior to and after COVID-19 vaccination in four large European electronic healthcare data sourcesSemantic proximity Read

Cardiac Inflammation after COVID-19 mRNA Vaccines: A Global Pharmacovigilance AnalysisSemantic proximity Read

Safety of SARS-CoV-2 vaccine in patients with autoimmune neurological conditions: a systematic review and meta-analysisSemantic proximity Read

Expanded Spectrum and Increased Incidence of Adverse Events Linked to COVID-19 Genetic Vaccines: New Concepts on Prophylactic Immuno-Gene Therapy, Iatrogenic Orphan Disease and Platform-Inherent ChallengesSemantic proximity Read

Nature Of, Immune Reaction to and Side Effects of COVID-19 Vaccines: Synthesis of Information Including Exclusions from Ten Phase II Trials for Planning Vaccination ProgrammesSemantic proximity Read

Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from GreeceSemantic proximity Read

Vaccines Associated Cardiac Adverse Events, including SARS-CoV-2 Myocarditis, Elevated Histamine Etiology HypothesisSemantic proximity Read